Cargando…
Sacral Neuromodulation in Patients With a Cardiac Pacemaker
The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With the increasingly widespread use of InterStim for bladder function restoration, we ar...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Continence Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083830/ https://www.ncbi.nlm.nih.gov/pubmed/27706012 http://dx.doi.org/10.5213/inj.1632536.268 |
_version_ | 1782463290784350208 |
---|---|
author | Gahzi, Abdullah A. Elterman, Dean S. Hassouna, Magdy |
author_facet | Gahzi, Abdullah A. Elterman, Dean S. Hassouna, Magdy |
author_sort | Gahzi, Abdullah A. |
collection | PubMed |
description | The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With the increasingly widespread use of InterStim for bladder function restoration, we are seeing more complex patients with multiple comorbidities, including cardiac conditions. Herein, we report 3 cases of individuals with cardiac pacemakers who underwent InterStim implantation to treat urinary conditions. This study is a case series of 3 patients with cardiac pacemakers who underwent sacral neuromodulation to treat refractory voiding dysfunction. The initial patient screening for InterStim therapy involved percutaneous nerve evaluation (PNE), in which a temporary untined lead wire was placed through the S3 foramen. Patients who did not respond to PNE proceeded to a staged implant. All patients in this study had a greater than 50% improvement of their urinary symptoms during the initial trial and underwent placement of the InterStim implantable pulse generator (IPG). Postoperative programming was done under electrocardiogram monitoring by a cardiologist. No interference was observed between the Inter-Stim IPG and the cardiac pacemaker. In this group of patients, sacral neuromodulation in the presence of a cardiac pacemaker appears to have been safe. |
format | Online Article Text |
id | pubmed-5083830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Korean Continence Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-50838302016-11-01 Sacral Neuromodulation in Patients With a Cardiac Pacemaker Gahzi, Abdullah A. Elterman, Dean S. Hassouna, Magdy Int Neurourol J Case Report The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With the increasingly widespread use of InterStim for bladder function restoration, we are seeing more complex patients with multiple comorbidities, including cardiac conditions. Herein, we report 3 cases of individuals with cardiac pacemakers who underwent InterStim implantation to treat urinary conditions. This study is a case series of 3 patients with cardiac pacemakers who underwent sacral neuromodulation to treat refractory voiding dysfunction. The initial patient screening for InterStim therapy involved percutaneous nerve evaluation (PNE), in which a temporary untined lead wire was placed through the S3 foramen. Patients who did not respond to PNE proceeded to a staged implant. All patients in this study had a greater than 50% improvement of their urinary symptoms during the initial trial and underwent placement of the InterStim implantable pulse generator (IPG). Postoperative programming was done under electrocardiogram monitoring by a cardiologist. No interference was observed between the Inter-Stim IPG and the cardiac pacemaker. In this group of patients, sacral neuromodulation in the presence of a cardiac pacemaker appears to have been safe. Korean Continence Society 2016-09 2016-09-23 /pmc/articles/PMC5083830/ /pubmed/27706012 http://dx.doi.org/10.5213/inj.1632536.268 Text en Copyright © 2016 Korean Continence Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Gahzi, Abdullah A. Elterman, Dean S. Hassouna, Magdy Sacral Neuromodulation in Patients With a Cardiac Pacemaker |
title | Sacral Neuromodulation in Patients With a Cardiac Pacemaker |
title_full | Sacral Neuromodulation in Patients With a Cardiac Pacemaker |
title_fullStr | Sacral Neuromodulation in Patients With a Cardiac Pacemaker |
title_full_unstemmed | Sacral Neuromodulation in Patients With a Cardiac Pacemaker |
title_short | Sacral Neuromodulation in Patients With a Cardiac Pacemaker |
title_sort | sacral neuromodulation in patients with a cardiac pacemaker |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083830/ https://www.ncbi.nlm.nih.gov/pubmed/27706012 http://dx.doi.org/10.5213/inj.1632536.268 |
work_keys_str_mv | AT gahziabdullaha sacralneuromodulationinpatientswithacardiacpacemaker AT eltermandeans sacralneuromodulationinpatientswithacardiacpacemaker AT hassounamagdy sacralneuromodulationinpatientswithacardiacpacemaker |